Article Information
History
- September 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joshua G. Liang1,*,
- Danmei Su1,*,
- Tian-Zhang Song2,*,
- Yilan Zeng3,*,
- Weijin Huang4,*,
- Jinhua Wu1,
- Rong Xu1,
- Peiwen Luo1,
- Xiaofang Yang1,
- Xiaodong Zhang1,
- Shuangru Luo1,
- Ying Liang1,
- Xinglin Li1,
- Jiaju Huang1,
- Qiang Wang1,
- Xueqin Huang1,
- Qingsong Xu1,
- Mei Luo3,
- Anliang Huang5,
- Dongxia Luo3,
- Chenyan Zhao4,
- Fan Yang5,
- Jian-Bao Han2,
- Yong-Tang Zheng2 and
- Peng Liang1,†
- 1Clover Biopharmaceuticals, Chengdu, China
- 2Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
- 3Public Health Clinical Center of Chengdu, Chengdu, China
- 4Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China
- 5Department of Pathology, Chengdu Fifth People’s Hospital, Chengdu, China
- ↵†Corresponding author. Email: liang.peng{at}cloverbiopharma.com
↵* These authors contributed equally to this work
Posted September 24, 2020.
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
